1 - 10 out of 27Page size: 10
  1. 2023

  2. Pharmacokinetic study of Tdp1 inhibitor resulted in a significant increase in antitumor effect in the treatment of Lewis lung carcinoma in mice by its combination with topotecan

    Okhina, A. A., Kornienko, T. E., Rogachev, A. D., Luzina, O. A., Popova, N. A., Nikolin, V. P., Zakharenko, A. L., Dyrkheeva, N. S., Pokrovsky, A. G., Salakhutdinov, N. F. & Lavrik, O. I., 30 Nov 2023, In: Journal of Pharmaceutical and Biomedical Analysis. 236, 9 p., 115731.

    Research output: Contribution to journal › Article › peer-review

  3. Effect of Usnic Acid-Derived Tyrosyl-DNA Phosphodiesterase 1 Inhibitor Used as Monotherapy or in Combination with Olaparib on Transplanted Tumors In Vivo

    Kornienko, T. E., Zakharenko, A. L., Ilina, E. S., Chepanova, A. A., Zakharova, O. D., Dyrkheeva, N. S., Popova, N. A., Nikolin, V. P., Filimonov, A. S., Luzina, O. A., Salakhutdinov, N. F. & Lavrik, O. I., Apr 2023, In: Molecular Biology. 57, 2, p. 214-224 11 p.

    Research output: Contribution to journal › Article › peer-review

  4. Impact of Double-Stranded RNA Internalization on Hematopoietic Progenitors and Krebs-2 Cells and Mechanism

    Ritter, G. S., Proskurina, A. S., Meschaninova, M. I., Potter, E. A., Petrova, D. D., Ruzanova, V. S., Dolgova, E. V., Kirikovich, S. S., Levites, E. V., Efremov, Y. R., Nikolin, V. P., Popova, N. A., Venyaminova, A. G., Taranov, O. S., Ostanin, A. A., Chernykh, E. R., Kolchanov, N. A. & Bogachev, S. S., 2 Mar 2023, In: International Journal of Molecular Sciences. 24, 5, 4858.

    Research output: Contribution to journal › Article › peer-review

  5. The Lipophilic Purine Nucleoside-Tdp1 Inhibitor-Enhances DNA Damage Induced by Topotecan In Vitro and Potentiates the Antitumor Effect of Topotecan In Vivo

    Chernyshova, I. A., Zakharenko, A. L., Kurochkin, N. N., Dyrkheeva, N. S., Kornienko, T. E., Popova, N. A., Nikolin, V. P., Ilina, E. S., Zharkov, T. D., Kupryushkin, M. S., Oslovsky, V. E., Drenichev, M. S. & Lavrik, O. I., Jan 2023, In: Molecules (Basel, Switzerland). 28, 1, 323.

    Research output: Contribution to journal › Article › peer-review

  6. 2022

  7. Experimental Study of Antitumor Activity of Pefagtal Addressed to αvβ3 Integrins

    Popova, N. A., Nikolin, V. P., Kaledin, V. I., Serova, I. A., Matyunina, E. A., Bakarev, M. A., Lushnikova, E. L. & Vologodskii, A. N., May 2022, In: Bulletin of Experimental Biology and Medicine. 173, 1, p. 105-109 5 p.

    Research output: Contribution to journal › Article › peer-review

  8. Changes in the number and morphology of blood cells in mice pretreated with RNA preparations and exposed to 8 Gy of gamma radiation

    Dubatolova, T. D., Ritter, G. S., Proskurina, A. S., Kisaretova, P. E., Nikolin, V. P., Popova, N. A., Ruzanova, V. S., Taranov, O. S., Kolchanov, N. A. & Bogachev, S. S., 2022, In: International Journal of Radiation Research. 20, 2, p. 361-368 8 p.

    Research output: Contribution to journal › Article › peer-review

  9. 2021

  10. The influence of an enamine usnic acid derivative (a tyrosyl-DNA phosphodiesterase 1 inhibitor) on the therapeutic effect of topotecan against transplanted tumors in vivo

    Nikolin, V. P., Popova, N. A., Kaledin, V. I., Luzina, O. A., Zakharenko, A. L., Salakhutdinov, N. F. & Lavrik, O. I., Oct 2021, In: Clinical and Experimental Metastasis. 38, 5, p. 431-440 10 p.

    Research output: Contribution to journal › Article › peer-review

  11. Experimental comparison of the in vivo efficacy of two novel anticancer therapies

    Ruzanova, V. S., Proskurina, A. S., Ritter, G. S., Efremov, Y. R., Nikolin, V. P., Popova, N. A., Naprimerov, V. A., Dolgova, E. V., Potter, E. A., Kirikovich, S. S., Levites, E. V., Mustafin, Z. S., Lashin, S. A., Burakova, E. A., Stetsenko, D. A., Ostanin, A. A., Chernykh, E. R. & Bogachev, S. S., Jul 2021, In: Anticancer research. 41, 7, p. 3371-3387 17 p.

    Research output: Contribution to journal › Article › peer-review

  12. Противоопухлевая активность комбинации топотекана и ингибитора тирозил-ДНК-фосфодиэстеразы 1 на модели асцитной карциномы Кребс-2 мыши

    Dyrkheeva, N. S., Zakharenko, A. L., Novoselova, E. S., Chepanova, A. A., Popova, N. A., Nikolin, V. P., Luzina, O. A., Salakhutdinov, N. F., Ryabchikova, E. I. & Lavrik, O. I., 1 Mar 2021, In: Molekuliarnaia biologiia. 55, 2, p. 312-317 6 p., 12.

    Research output: Contribution to journal › Article › peer-review

  13. Antitumor Activity of the Combination of Topotecan and Tyrosyl-DNA-Phosphodiesterase 1 Inhibitor on Model Krebs-2 Mouse Ascite Carcinoma

    Dyrkheeva, N. S., Zakharenko, A. L., Novoselova, E. S., Chepanova, A. A., Popova, N. A., Nikolin, V. P., Luzina, O. A., Salakhutdinov, N. F., Ryabchikova, E. I. & Lavrik, O. I., Mar 2021, In: Molecular Biology. 55, 2, p. 273-277 5 p.

    Research output: Contribution to journal › Article › peer-review

Previous 1 2 3 Next

ID: 3438434